What is the company's size? (Annual sales and employees)
What industry is the company in?
Trademark applications show the products and services that Bioverativ is developing and marketing.
Bioverativ's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
GIVJOVA Pharmaceutical product to treat cold agglutinin disease (CAgD)
ENJAYMO Pharmaceutical product to treat cold agglutinin disease (CAgD)
Determine whether Bioverativ grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Bioverativ is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
A competitive analysis shows these companies are in the same general field as Bioverativ, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Bioverativ.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Bioverativ and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.